FDA Clears Shape Memory Medical's Impede Embolization Plug

 

June 26, 2018—Shape Memory Medical Inc. announced that it has received 510(k) clearance from the US Food and Drug Administration for its Impede embolization plug, which is indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature. The device, which features the company's Shape Memory Polymer (SMP), is available in three sizes to treat vessels up to 10 mm in diameter.

The Impede embolization plug received European CE Mark approval in August 2017 and has been used to treat patients in New Zealand and in several countries in the European Union.

According to the company, the Impede device's SMP technology features porous polymeric materials capable of changing from a catheter-deliverable shape to a “memorized” larger conformable shape when delivered into a blood vessel. The company continues to develop SMP technology for an expanded range of clinical uses, including neurovascular applications.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.